Literature DB >> 17713420

Restoration of hormonal action and muscle protein.

Arny A Ferrando1, Robert R Wolfe.   

Abstract

This review focuses on the effects of restoring hormonal levels and/or influence on muscle protein metabolism in the stressed state. We have highlighted our clinical experience in the administration of anabolic and anticatabolic agents in stressed clinical populations, primarily adult and pediatric burn injury, as well as patients undergoing elective hip arthroplasty. Our previous experience entails the administration of anabolic hormones, such as testosterone and its derivatives, growth hormone, insulin-like growth factor-1 combined with its binding protein 3, and insulin. Current efforts focus on the administration of anticatabolic agents to reduce the effects of hypercortisolemia. Muscle protein metabolism was determined by stable isotope methodology. Our results indicate that normalization of anabolic hormone concentrations or amelioration of hormonal resistance restores the effects of feeding on skeletal muscle protein metabolism. Anabolic hormone administration results in a more favorable muscle protein balance in severely burned patients. Amelioration of hypercortisolemia in the stressed state leads to an improvement in protein kinetics. To summarize, alterations in hormonal influence that accompany stress states favor the loss of muscle protein. Restoration or normalization of hormonal influence improves muscle protein kinetics and ameliorates the loss of muscle nitrogen. To restore hormonal influence, clinicians should consider reestablishing anabolic stimuli and reducing catabolic stimuli.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713420     DOI: 10.1097/01.CCM.0000278529.44899.57

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Nutrition, anabolism, and the wound healing process: an overview.

Authors:  Robert H Demling
Journal:  Eplasty       Date:  2009-02-03

Review 2.  Current problems in burn hypermetabolism.

Authors:  Christian Sommerhalder; Elizabeth Blears; Andrew J Murton; Craig Porter; Celeste Finnerty; David N Herndon
Journal:  Curr Probl Surg       Date:  2019-11-11       Impact factor: 1.909

Review 3.  Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.

Authors:  Eduardo I Gus; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Burns       Date:  2019-12-15       Impact factor: 2.744

4.  Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia.

Authors:  Alexander Skorokhod; Jeannine Bachmann; Nathalia A Giese; Marc E Martignoni; Holger Krakowski-Roosen
Journal:  BMC Cancer       Date:  2012-06-21       Impact factor: 4.430

5.  The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes.

Authors:  Marc G Jeschke; Felicia N Williams; Celeste C Finnerty; Noe A Rodriguez; Gabriela A Kulp; Arny Ferrando; William B Norbury; Oscar E Suman; Robert Kraft; Ludwik K Branski; Ahmed M Al-mousawi; David N Herndon
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

6.  Overexpression of Glucocorticoid Receptor β Enhances Myogenesis and Reduces Catabolic Gene Expression.

Authors:  Terry D Hinds; Bailey Peck; Evan Shek; Steven Stroup; Jennifer Hinson; Susan Arthur; Joseph S Marino
Journal:  Int J Mol Sci       Date:  2016-02-11       Impact factor: 5.923

7.  Insulin therapy improves protein metabolism in the critically ill.

Authors:  Elena Bogdanovic; Marc G Jeschke
Journal:  Crit Care       Date:  2012-05-14       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.